awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38093654-2B0D1317-F287-4243-B40E-7D1C0D18476F
Q38093654-2B0D1317-F287-4243-B40E-7D1C0D18476F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38093654-2B0D1317-F287-4243-B40E-7D1C0D18476F
Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
P2860
Q38093654-2B0D1317-F287-4243-B40E-7D1C0D18476F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38093654-2B0D1317-F287-4243-B40E-7D1C0D18476F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c8c123fbdf4234d87eb8eb7f5684013a71303a7
P2860
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).